United States · Bill · HR
H.R. 19 (116th)
Lower Costs, More Cures Act of 2019
Introduced
9 December 2019
Last action
—
Status
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
Lower Costs, More Cures Act of 2019 This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, modifies certain authorities and requirements under the Medicaid Drug Rebate Program, revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and establishes several reporting requirements for drug manufacturers with respect to drug prices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 9 December 2019
Introduced in House (PDF)
Introduced in House · EN · 9 December 2019
Introduced in House
summary · EN · 9 December 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/19
- Open data entity: https://api.congress.gov/v3/bill/116/hr/19